Neutrophil influx measured in nasal lavages of humans exposed to ozone

Archives of Environmental Health

Volumn 43, Issue 3, 1988, Pages 228-233

  Graham, Delores ^a   Henderson, Frederick ^b   House, Dennis ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDIZING AGENT; OZONE;

ADULT; ANIMAL EXPERIMENT; EXPERIMENT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RHINITIS; RHINOVIRUS; UPPER RESPIRATORY TRACT;

ADOLESCENT; ADULT; AIR POLLUTANTS; ATMOSPHERE EXPOSURE CHAMBERS; COMMON COLD; DOUBLE-BLIND METHOD; HUMANS; INFLAMMATION; IRRIGATION; LEUKOCYTE COUNT; MALE; NASAL MUCOSA; NEUTROPHILS; OZONE; RANDOM ALLOCATION;

ANIMALIA; RHINOVIRUS;

EID: 0023888947     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039896.1988.9934938     Document Type: Article

References (39)

1. Air Quality Criteria for Ozone and Other Photochemical Oxidants. Vol. iii, EPA-600/8-78-004.
2. Kasel, J. A.; Six, H. R.; Oborn, C. J.; and Dreesman, G. R. 1978. Immunoglobulin-specific radioimmunoprecipitation assays for quantitation ot nasal secretory antibodies to hemagglutinin of Type A Influenza viruses. J Clin Microbiol 8:171-176.
3. Rossen, R. D.; Butler, W. T.; Cate, R. T.; Szwed, C. F.; and Couch, R. B. 1965. Protein composition of nasal secretion during respiratory virus infection. Proc Soc Exp Biol Med 119:1169-76.
4. Brandtzaeg, P. 1984. Immune function of human nasal mucosa and tonsils in health and diseases. In: Immunology of the Lung and Upper Respiratory Tract, J. Bienenstock, Ed., Ch 2. NY: McGraw-Hill.
5. Mygind, N.; Weeke, B.; and Ullman, S. 1975. Quantitative deter-mination of immunoglobulins in nasal secretion. Int Arch Allergy Appl Immunol 49:99-107.
6. Hunninghake, G. W. and Crystal, R. 1983. Cigarette smoking and lung destruction: Accumulation of neutrophils in the lung of cigarette smokers. Amer Rev Respir Dis 128:833-38.
7. Kilburn, K. 1984. Particles causing lung disease. Environ Health Persp 55:75-109.
8. Henderson, R. F.; Rebar, A. H.; Pickerell, J. A.; and Newton, G. J. 1979. Early damage indicators in the lung. III. Biochemical and cytological response of the lung to inhaled metal salts. Toxicol Applied Pharmacol 50:123-36.
9. Yamada, H.; Damiano, V. V.; Tsang, A.; Meranze, D.; Glasgow, J.; Abrams, W. R.; and Weinbaum, G. 1982. Neutrophil degranulation in CD-chloride induced acute lung inflammation. Am J Pathol 109:145-56.
10. Luciano, E. M.; Dauber, J. H.; and Daniele, R. P. 1982. Acute ex-perimental silicosis. Am J Pathol 109:27-36.
11. Gardner, D. E.; Lewis, T. R.; Alpert, S. M.; Hurst, D. J.; and Coffin, D. L. 1972. The role of tolerance in pulmonary defense mech-anisms. Arch Environ Health 25:432-38.
12. Castleman, W. L.; Dungworth, D. L.; Schwartz, L. W.; and Tyler, W. S. 1980. Acute respiratory bronchiolitis: An ultra structural and autoradiographic study of epithelial cell injury and renewal in Rhesus monkeys exposed to ozone. Am J Pathol 98:811-40.
13. Brummer, M. E.; Schwartz, L. W.; and McQuillen, N. K. 1977. A quantitative study of lung damage by scanning electron micros-copy. Inflammatory cell response to high ambient levels of ozone. Scanning Electron Microscopy 2:513-18.
14. Warr, G. A. and Jakab, G. J. 1983. Pulmonary inflammatory re-sponse during viral pneumonia and secondary bacterial infec-tion. Inflammation 7:93-104.
15. Alpert, S. M.; Gardner, D. E.; Hurst, D. J.; Lewis, T. R.; and Coffin, D. L. 1971. Effects of exposure to ozone on defensive mech-anisms of the lung. J Appl Physiol 31:247-52.
16. Holtzman, M. J.; Fabbri, L. M.; O'Bryne, P. M.; Gold, B. D.; Aoi- zawa, H.; Walters, E.; Alpert, J. E.; and Nadel, J. A. 1983. Impor-tance of airway inflammation four hyperresponsiveness induced by ozone. Am Rev Respir Dis 127:686-90.
17. Scheel, L. D.; Dobrogorski, O. J.; Mountsin, J. T.; Sverbely, J. L.; and Stokinger, H. E. 1959. Physiologic, biochemical, immuno-logic, and pathologic changes following ozone exposure. J Appl Physiol 14:67-80.
18. DeLucia, A. J.; Hogue, P. M.; Mustafa, M. G.; and Cross, C. E. 1972. Ozone interaction with rodent lung, effect on sulfhydryls and sulfhydryl-containing enzyme activities. J Lab Clin Med 80:559-66.
19. Strong, A. A. 1978. Description of the CLEANS human exposure system. EPA-600/1-78-064.
20. Henderson, F. W.; Dubovi, E. J.; Harder, S.; Seal, E.; and Graham, D. 1986. Experimental rhinovirus infection in human volunteers exposed to ozone (in press, ARRD).
21. Hu P. C.; Miller, F. G.; Daniels, M. J.; Hatch, G. E.; Graham, J. A.; Gardner, D. E.; and Selgrade, M. K. 1982. Protein accumulation n lung lavage fluid following ozone exposure. Environ Res 29:377-88.
22. Powell, K. R.; Shorr, R.; Cherry, J. D.; and Hendley, J. O. 1977. Improved method for collection of nasal mucus. J Infect Dis 136:109-11.
23. Brain, J. D. and R. Frank. 1973. Alveolar macrophage adhesion: Wash electrolyte composition and free cell yield. J Appl Physiol 34:75-80.
24. Hendley, J. O. 1983. Rhinovirus colds: Immunology and patho-genesis. Eur Respir Dis 64(S128):340-43.
25. Dunnett, C. W. 1955. A multiple comparison procedure for com-paring several treatments with a control. J Am Stat Assoc 50: 1096-1121.
26. Jorden, E. O. and Carlson, A. J. 1913. Ozone: Its bactericidal, physiologic, and deodorizing action. J Amer Med Assoc 61: 1007-12.
27. Cerrity, T. R.; Weaver, R. A.; Berntsen, J. H.; and O'Neil, J. J. 1986. Nasopharnygeal and lung removal of ozone during tidal breathing in man. The Physiologist 29(4): 173.
28. Mygind, N.; Pederson, M.; and Nielsen, M. H. 1982. Morphology of the upper airway epithelium. In: The Nose: Upper Airway Physiology and the Atmospheric Environment, Proctor and Anderson, Eds., pp. 71-94. NY: Elsevier.
29. Proctor, D. F. 1979. Tests of airway defense mechanisms. In: The Lung in the Transition between Health and Disease P. T. Malkin and S. Permutt, Eds., Ch. 9, pp. 227-39. New York: Marcel Dek- ker, Inc.
30. Cole, P. and Stanley, P. 1983. The importance of nasal symptoms to the chest physician. European I Respir Dis (Suppl.) 126:64.
31. Alpert, S. M.; Lewis, E. R.; and Schwrat, B. B. 1971. Alveolar pro-tein accumulation: A sensitive indicator of low level oxidant tox-icity. Arch Intern Med 128:69-73.
32. Seltzer, J.; Bigby, B.; Stulbarg, M.; Holtzman, M.; Nadel, J.; Ueki, I.; Leikauf, C.; Coetzel, E.; and Boushey, H. 1986. OJ-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 60:1321-26.
33. Atkins, P. C.; Norman, M.; Weiner, H.; and Zweiman. 1977. Release of Neutrophil chemotactic activity during immediate hyper-sensitivity reactions in humans. Annals Int Med 86:415-17.
34. Hunninghake, G; Cadek, J. E.; and Fales, H. M. 1980. Human al-veolar macrophage-derived chemotactic factor for neutrophils. J Clin Invest 66:473-80.
35. Malmsten, C. L. 1984. Leukotrienes: Mediators of inflammation and immediate hypersensitivity reactors. CRC Crit Rev Immunol 4:307-334.
36. Snapper, J. R. and Brigham, K. L. 1984. Inflammation and airway reactivity. Exp Lung Res 6:83-89.
37. Janoff, A.; Whitte, R.; Carp, H.; Harel, S.; Dearing, R.; and Lee, D. 1979. Lung injury induced by leukocytic proteases. Am J Pathol 97:111-36.
38. Janoff, A.; Sloan, B.; and Weinbaum, G. 1977. Experimental em-physema induced with purified human neutrophil elastase. Am Rev Respir Dis 115:461-78.
39. Keogh, B.; Line, B.; Rust, M.; Hunninghake, G.; Meursydoro, J.; and Crystal, R. 1981. Clinical staging of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 123:89.